Balto Pharmaceuticals, Inc. is a preclinical stage company focused on the discovery and development of game-changing drugs that target protein-protein interactions for the treatment of cancer and other diseases. Since its inception in 2015, Balto has been focused on some of the toughest undruggable targets by using proprietary transformative platform technologies, so to create new therapeutic drugs that the world has never seen. For collaboration, investment or employment, please contact us.